Bridge by CliniContact · US & UK

Reach patients through the organizations they already trust.

Paid ads only find the patients already searching. Bridge reaches the rest, through the advocacy groups, community clinics and provider networks that already serve your study population, and turns them into a compliant referral engine for your trial.

For sponsors, site networks, SMOs and CROs.

See it in action

A real community outreach strategy

A study-specific plan Bridge builds straight from the protocol: the conversion funnel, the per-site reach and underserved makeup, the partner universe by channel, and a month-by-month program that works it.

Page through a full strategy Bridge produced.

A real (demo) plan end to end: funnel, reach, partner channels, catchment map and the six-month program.

Open the full strategy →
Why it matters

Research should reach everyone, not just the easy to find.

Clinical trials have a reach problem. The people who could benefit most, families facing a rare diagnosis, patients in rural towns, communities research has long overlooked, are too often the last to hear that a study even exists.

Bridge changes who gets asked. Instead of cold ads, we reach people through the advocacy groups, clinics and community leaders they already know. When an invitation comes from someone you trust, it lands differently, and doors that used to stay closed start to open.

It is also how a Diversity Action Plan gets carried out, not just filed.

🤝

Built on trust

We meet patients where they already are, through organizations that earned their community's trust over years, not overnight.

🌍

Access for the overlooked

Rural, underserved and historically excluded communities get a real seat at the table, not an afterthought once enrollment stalls.

💙

People, not leads

Every referral is someone's mother, son or neighbor, getting a chance they might never have heard about otherwise.

What Bridge does

An end-to-end community-outreach engine, built to reach patients through the people and organizations they already trust.

🎯

Finds the right partners

We pinpoint the advocacy groups, clinics, provider networks and community organizations that already reach your study population, matched to your indication and catchment area, and carefully curated so outreach is targeted, never spam.

📣

Meets communities on every channel

We engage partners the way they actually connect: email, social and professional networks, with respectful, fully compliant, opt-out-friendly messaging that never over-contacts one organization.

💬

Turns interest into referrals

Every reply gets a real response. Interested partners are guided to refer patients to the right study, and each relationship is kept warm and respectful across the whole organization.

🧭

A welcoming front door for patients

A clean, patient-friendly study finder helps interested people find the right study and next step by condition and location, the trusted entry point for community referrals.

🗂️

Built for multi-site programs

Running one indication across many sites? We engage the community once and connect each interested patient to their best-fit site, with a single rolled-up view across the whole program.

📊

Live visibility for your team

Log in any time to watch engagement, referrals and your community footprint update in real time, progress you can see unfold, not a weekly status deck.

The network your study plugs into

A standing network of relationships, mapped to real communities, that a study can plug into on day one.

1,094
Partner organizations
2,399
Network contacts
87.9M
People in reach
428
Communities

Across 52 states and 26 studies to date, weighted to the community providers and advocacy groups that reach patients where they are.

61.3%

of the people our network reaches are from under-represented communities, against a 42.6% national baseline. That is 53.9M people a study can reach.

29.6%
Hispanic or Latino
16.3%
Black
9.9%
Asian

Representation across the network footprint. This is what turns a Diversity Action Plan into something you can evidence, not just state.

Types of partners

Community providers and clinics52%
Advocacy organizations20%
Academic medical centers10%
Researchers and KOLs5%
Specialist clinics4%
Other partners9%

How the network is built

  • Verified organizations. Built from public patient-organization and health registries, confirmed active for your indication.
  • Advocacy and foundation mapping. The disease-specific organizations that families in your indication already turn to.
  • Matched to your study. Filtered to your indication and each site's catchment, then human-reviewed before anyone is contacted.
  • Institutional memory. Every relationship is remembered across studies, so the next trial starts warm.

Conditions and specialties worked across

Inherited metabolic disordersNeurologyAddiction and substance useHearing and deafnessPsychiatry and behavioral healthHematologyRare and genetic conditionsPediatricsNeuromuscular 41 specialties in all

A snapshot of the live network. Log in to your dashboard for your study's own footprint and per-study breakdown.

Built for the US and the UK

One outreach engine, tuned to each market's networks and rules.

🇺🇸

United States

Community health centers, FQHCs, patient advocacy foundations and provider networks, with catchment demographics from the US Census Bureau. Outreach aligned to FDA and IRB recruitment standards and HIPAA, and built to evidence a Diversity Action Plan.

🇬🇧

United Kingdom

NHS trusts, primary care networks, disease charities and community groups, aligned to HRA and Research Ethics Committee expectations and UK GDPR. Reach into under-served communities that a paid-media-only approach rarely touches.

How it works

1

Define the study

We build an indication-level partner profile: the org types, specialties and geographies that reach your population.

2

Find and vet partners

We build a targeted, vetted list of the organizations and people who genuinely fit your study. Quality over quantity, no spam lists.

3

Engage and refer

We reach out respectfully across the right channels, respond to every reply, and help interested partners refer patients to the right study.

4

See the results

Track engagement, referrals and the community footprint live in your client dashboard.

Proof of breadth

The organizations Bridge can reach for your indication

A live count of the registered patient organizations and health charities Bridge can mobilize, across the conditions the model is built for. Every figure is a real directory count, in both markets.

United States United Kingdom

CNS & psychiatry

Depression, Alzheimer's, Parkinson's, epilepsy, MS, ALS, schizophrenia, Huntington's

US
1,873
UK
444
US
UK

Oncology

Breast cancer, multiple myeloma

US
1,179
UK
57
US
UK

Rare & genetic

Sickle cell disease, cystic fibrosis

US
233
UK
35
US
UK

Autoimmune

Lupus, rheumatoid arthritis

US
207
UK
39
US
UK
3,492
US organizations across these conditions
575
UK organizations across these conditions
See every indication
Breast cancer
823
51
Depression (MDD)
433
192
Multiple myeloma
356
6
Alzheimer's
325
138
Parkinson's
313
27
Multiple sclerosis
253
32
ALS / MND
211
4
Sickle cell disease
190
24
Epilepsy
189
26
Lupus (SLE)
131
8
Huntington's
78
23
Rheumatoid arthritis
76
31
Schizophrenia
71
2
Cystic fibrosis
43
11

The CliniContact platform

Bridge is one half of how CliniContact fills a study

CliniContact runs two recruitment engines that share one participant record. Most studies use both: Horizon reaches the patients who are searching, Bridge reaches the ones who are not.

HorizonStudy startup & digital recruitment

Give Horizon a protocol link or PDF, and about an hour later you have the full recruitment package and a study-specific marketing strategy, screened for IRB and platform compliance. Then we build and run the digital ad campaigns, tuned weekly to cost-per-qualified-candidate.

  • Recruitment package + marketing strategy in about an hour
  • Managed paid-media campaigns; you set the ad spend, no markup
  • Smart Screener and Vision included
See Horizon →
BridgeCommunity & referral pathways

The community-outreach engine on this page. Bridge reaches patients through the advocacy groups, clinics and communities that already serve them, and turns those relationships into a compliant referral pathway, built to evidence a Diversity Action Plan.

  • Partner networks matched to your indication and catchment
  • Reaches underserved communities paid media misses
  • Smart Screener and Vision included
You are here ↑

One participant record across both, so a lead from a Facebook group and a lead from a paid ad land in the same place, screened the same way.

Pricing

Priced per indication, not per study

One indication covers every study you run in it. Bridge is priced by how hard the community is to reach, and nothing else. No management fee, no markup.

Established communities

$1,200/ indication / month

High-prevalence conditions with broad advocacy and community networks already in place.

DepressionAlzheimer'sParkinson'sEpilepsyBreast cancerRheumatoid arthritis
Most common

Complex reach

$1,500/ indication / month

Specialized communities with fewer, harder-to-find partners, and more field-building to open the pathways.

Multiple sclerosisSickle cell diseaseSchizophreniaLupusMultiple myeloma

Rare & hardest

$1,800/ indication / month

Ultra-low prevalence and tightly concentrated communities, where every partner counts.

ALS / MNDHuntington'sCystic fibrosis
New to Bridge? Run one study on the full Horizon + Bridge engine for $1,200/mo, with $300 toward your first month of ad spend. Start your pilot →

No management fee · No ad-spend markup · No per-seat or setup fees

Minimum term: Horizon 3 months, Bridge 6 months. Community outreach needs the runway to build partner relationships.

Running several indications or a site network? Request a full quote →

Bring community reach to your next study.

Log in to your Bridge dashboard to see live progress, or talk to our team about standing up outreach for a new study.

Prefer email? info@bridge-by-clinicontact.com